Treace Medical Concepts (TMCI) Metrics: History & Chart

Treace Medical Concepts, Inc.(TMCI)

Medical - Devices · Ponte Vedra, FL

$4.00-0.48 (-10.71%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Ponte Vedra, FL

450 employees

www.treace.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: John T. Treace

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	0.00%
30D Total Return	-6.86%
YTD Total Return	+82.86%
1Y Total Return	-29.56%
3Y Total Return	-63.55%
5Y Total Return	-82.47%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+82.86%
2025	-67.07%
2024	-41.65%
2023	-44.54%
2022	+23.34%
2021	N/A

CAGR TTM	-29.44%
CAGR 3Y	-28.56%
CAGR 5Y	-29.41%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

TMCI Valuation Metrics

TMCI Stock Price Metrics

TMCI Dividend Metrics

TMCI Growth Rate Metrics

TMCI Discounted Cash Flow Metrics

TMCI Returns By Period

TMCI Yearly Returns

TMCI Average Annual Returns By Period (CAGR)

TMCI Revenue Metrics

TMCI PE Ratio Metrics

TMCI PS Ratio Metrics

TMCI PB Ratio Metrics

TMCI Price to Free Cash Flow Ratio Metrics

TMCI Debt to Equity Ratio Metrics

TMCI PEG Ratio Metrics

TMCI FCF Yield

TMCI Earnings Yield

TMCI EBITDA Yield

TMCI OCF Yield

TMCI EV/EBIT Ratio Metrics

TMCI EV/EBITDA Ratio Metrics

TMCI EV/Assets Ratio Metrics

TMCI EV/Sales Ratio Metrics

TMCI Current Ratio Metrics

TMCI Quick Ratio Metrics

TMCI ROIC Metrics

TMCI Return on Assets Metrics

TMCI Return on Equity Metrics

TMCI Net Profit Margin Metrics

TMCI Gross Profit Margin Metrics

TMCI Tax Rate Metrics

PS Ratio	1.42
PS Ratio Avg TTM	1.03
PS Ratio Avg 3Y	1.92
Current VS TTM Avg	+37.85%
Current VS 3Y Avg	-26.15%
Current VS 5Y Avg	-73.21%

PB Ratio	4.30
PB Ratio Avg TTM	2.68
PB Ratio Avg 3Y	3.74
Current VS TTM Avg	+60.46%
Current VS 3Y Avg	+15.01%
Current VS 5Y Avg	-33.89%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	1.07
Debt/Equity Ratio Avg TTM	0.58
Debt/Equity Ratio Avg 3Y	0.61
Current VS TTM Avg	+84.01%
Current VS 3Y Avg	+75.52%
Current VS 5Y Avg	+86.67%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	2196.36
Ev/Ebit Ratio Avg TTM	2223.35
Ev/Ebit Ratio Avg 3Y	2223.35
Current VS TTM Avg	-1.21%
Current VS 3Y Avg	-1.21%
Current VS 5Y Avg	-1.21%

Ev/Ebitda Ratio	854.94
Ev/Ebitda Ratio Avg TTM	879.29
Ev/Ebitda Ratio Avg 3Y	879.29
Current VS TTM Avg	-2.77%
Current VS 3Y Avg	-2.77%
Current VS 5Y Avg	-2.77%

Ev/Assets Ratio	1.94
Ev/Assets Ratio Avg TTM	1.33
Ev/Assets Ratio Avg 3Y	2.10
Current VS TTM Avg	+46.08%
Current VS 3Y Avg	-7.65%
Current VS 5Y Avg	-51.46%

Ev/Sales Ratio	1.71
Ev/Sales Ratio Avg TTM	1.20
Ev/Sales Ratio Avg 3Y	2.19
Current VS TTM Avg	+42.64%
Current VS 3Y Avg	-21.74%
Current VS 5Y Avg	-67.91%

Current Ratio	2.90
Current Ratio Avg TTM	3.54
Current Ratio Avg 3Y	4.07
Current VS TTM Avg	-17.95%
Current VS 3Y Avg	-28.66%
Current VS 5Y Avg	-48.02%

Quick Ratio	1.95
Quick Ratio Avg TTM	2.50
Quick Ratio Avg 3Y	3.08
Current VS TTM Avg	-21.89%
Current VS 3Y Avg	-36.74%
Current VS 5Y Avg	-58.32%

ROIC	(37.64%)
ROIC Avg 3Y	(30.51%)
ROIC Avg 5Y	(25.21%)
Current VS 3Y Avg	-23.36%
Current VS 5Y Avg	-49.29%
Current VS 10Y Avg	-49.29%

ROA	(32.87%)
ROA Avg TTM	(8.03%)
ROA Avg 3Y	(6.70%)
Current VS TTM Avg	-309.19%
Current VS 3Y Avg	-390.50%
Current VS 5Y Avg	-418.97%

ROE	(87.86%)
ROE Avg TTM	(68.21%)
ROE Avg 3Y	(50.86%)
Current VS TTM Avg	-28.80%
Current VS 3Y Avg	-72.75%
Current VS 5Y Avg	-84.79%

Net Profit Margin	(28.99%)
Net Profit Margin Avg TTM	(31.44%)
Net Profit Margin Avg 3Y	(36.30%)
Current VS TTM Avg	+7.80%
Current VS 3Y Avg	+20.14%
Current VS 5Y Avg	+3.50%

Gross Profit Margin	79.45%
Gross Pft Margin Avg TTM	79.42%
Gross Pft Margin Avg 3Y	80.13%
Current VS TTM Avg	+0.04%
Current VS 3Y Avg	-0.85%
Current VS 5Y Avg	-1.51%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A